Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 312

Similar articles for PubMed (Select 20610650)


Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis.

Dunne A, Ross PJ, Pospisilova E, Masin J, Meaney A, Sutton CE, Iwakura Y, Tschopp J, Sebo P, Mills KH.

J Immunol. 2010 Aug 1;185(3):1711-9. doi: 10.4049/jimmunol.1000105. Epub 2010 Jul 7.


Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production.

Brereton CF, Sutton CE, Ross PJ, Iwakura Y, Pizza M, Rappuoli R, Lavelle EC, Mills KH.

J Immunol. 2011 May 15;186(10):5896-906. doi: 10.4049/jimmunol.1003789. Epub 2011 Apr 13.


Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.

Lalor SJ, Dungan LS, Sutton CE, Basdeo SA, Fletcher JM, Mills KH.

J Immunol. 2011 May 15;186(10):5738-48. doi: 10.4049/jimmunol.1003597. Epub 2011 Apr 6.


Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways.

Fedele G, Spensieri F, Palazzo R, Nasso M, Cheung GY, Coote JG, Ausiello CM.

PLoS One. 2010 Jan 15;5(1):e8734. doi: 10.1371/journal.pone.0008734.


Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.

Higgins SC, Lavelle EC, McCann C, Keogh B, McNeela E, Byrne P, O'Gorman B, Jarnicki A, McGuirk P, Mills KH.

J Immunol. 2003 Sep 15;171(6):3119-27.


Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan.

Kumar H, Kumagai Y, Tsuchida T, Koenig PA, Satoh T, Guo Z, Jang MH, Saitoh T, Akira S, Kawai T.

J Immunol. 2009 Dec 15;183(12):8061-7. doi: 10.4049/jimmunol.0902477.


TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

Higgins SC, Jarnicki AG, Lavelle EC, Mills KH.

J Immunol. 2006 Dec 1;177(11):7980-9.


An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.

Majlessi L, Simsova M, Jarvis Z, Brodin P, Rojas MJ, Bauche C, Nouzé C, Ladant D, Cole ST, Sebo P, Leclerc C.

Infect Immun. 2006 Apr;74(4):2128-37.


Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.

Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH.

PLoS Pathog. 2013;9(4):e1003264. doi: 10.1371/journal.ppat.1003264. Epub 2013 Apr 4.


Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.

Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J.

Vaccine. 2004 Oct 22;22(31-32):4270-81.


Inflammasome recognition of influenza virus is essential for adaptive immune responses.

Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A.

J Exp Med. 2009 Jan 16;206(1):79-87. doi: 10.1084/jem.20081667. Epub 2009 Jan 12.


Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.

Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, Coote JG.

Infect Immun. 2006 Dec;74(12):6797-805. Epub 2006 Sep 18.


Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells.

Chen X, Howard OM, Oppenheim JJ.

J Immunol. 2007 May 15;178(10):6123-9.


Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice.

Orr B, Douce G, Baillie S, Parton R, Coote J.

Vaccine. 2007 Jan 2;25(1):64-71. Epub 2006 Jul 31.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk